|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Surface-enhanced laser desorption/ ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors 显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，： | 1 |
| 2 | Surface 2enhanced laser de- sorption/ionizationtime of flight mass spectrometry protein profiling i- dentifies ubiquitin and ferritin light chain as prognostic biomarkers in node2 negetive breast cancer tumors 显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，： | 1 |
| 3 | Translocation t( 11 ; 14) (q13;q32) is the hallmark of IgM, IgE, and nonsecretory muhiple myeloma variants 显示文摘 | Avet -Loiseau H Garand R Lode L | 2003 | Blood2003，101，4： | 1 |
| 4 | Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 5 | Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors 显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 6 | Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 7 | Use of multiepitope polyproteins in serodiagnosis of active tuberculosis显示文摘 | Houghton R L Lodes M J Dillon D C | 2002 | Clin Diagn Lab Immunol2002，9，4： | 1 |
| 8 | Meropenem: clinical response in relation to in vitro susceptibility显示文摘 | DRUSANO G L LODE H EDWARDS J R | 2000 | Clin Microbiol Infect2000，6，： | 1 |
| 9 | 3D printing of patient-specific implants for osteochondral defects: workflow for an MRI-guided zonal design显示文摘Magnetic resonance imaging(MRI)is a common clinical practice to visualize defects and to distinguish different tissue types and pathologies in the human body.So far,MRI data have not been used to model and generate a patient-specific design of multilayered tissue substitutes in the case of interfacial defects.For orthopedic cases that require highly individual surgical treatment,implant fabrication by additive manufacturing holds great potential.Extrusion-based techniques like 3D plot-ting allow the spatially defined application of several materials,as well as implementation of bioprinting strategies.With the example of a typical multi-zonal osteochondral defect in an osteochondritis dissecans(OCD)patient,this study aimed to close the technological gap between MRI analysis and the additive manufacturing process of an implant based on dif-ferent biomaterial inks.A workflow was developed which covers the processing steps of MRI-based defect identification,segmentation,modeling,implant design adjustment,and implant generation.A model implant was fabricated based on two biomaterial inks with clinically relevant properties that would allow for bioprinting,the direct embedding of a patient’s own cells in the printing process.As demonstrated by the geometric compatibility of the designed and fabricated model implant in a stereolithography(SLA)model of lesioned femoral condyles,a novel versatile CAD/CAM workflow was successfully established that opens up new perspectives for the treatment of multi-zonal(osteochondral)defects. | David Kilian Philipp Sembdner Henriette Bretschneider Tilman Ahlfeld Lydia Mika Jörg Lützner Stefan Holtzhausen Anja Lode Ralph Stelzer Michael Gelinsky | 2021 | Bio-Design and Manufacturing2021，4，4： | 1 |
| 10 | Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors 显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 11 | Surface-enhanced laser desorption/ionization time of flight spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node- negative breast cancer tumors 显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 12 | Information sharing in a supply chain with horizontal competition显示文摘 | Lode L | 2002 | Management Science2002，48，9： | 1 |
| 13 | Surface-en-hanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node2negative breast cancer tumors显示文摘 | Ricolleau G Charbonnel C Lode L | | 0，，06： | 1 |
| 14 | Mutations in TP53are exclusively associated with del(17p)in multiple myeloma显示文摘 | Lode L Eveillard M Trichet V | 2010 | Haematologica2010，95，： | 1 |
| 15 | Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a maerolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multieenter study of clinical efficacy and tolerability显示文摘 | Lode H File TM ]r Mandell L et at | 2002 | Clin Ther2002，24，11： | 1 |
| 16 | Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors显示文摘 | Ricolleau G Charbonnel C Lode L | 2006 | Proteomics2006，6，6： | 1 |
| 17 | Cournot Oligopoly with Information Sharing显示文摘 | Lode L | 1985 | Rand Journal of Economics1985，16，4： | 1 |
| 18 | Translocalion t(l 1;14)(q13;q32) is the hallmark of lgM, lgE and nonseeretory multiple myeloma variants显示文摘 | Avet-Loiseau H Garand R Lode L | 2003 | Blood2003，101，4： | 1 |
| 19 | Prediction of survival in multiple myeloma based on gene expression profi les reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome显示文摘 | Decaux 0 Lode L Magrangeas F | 2008 | J Clin Oncol2008，26，29： | 1 |
| 20 | Influence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly( methylmethacrylate) nanoparticles in experimental tumor models 显示文摘 | Fichtner I Kreuter J | 2001 | Pharm Res2001，18，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员